All Cancer Microbiology articles
-
NewsProbiotic delivers anticancer drug to the gut
Researchers have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.
-
NewsNew evidence links gut microbiome to chronic disease outcomes
A new review consolidates recent findings that demonstrate a causal role for the gut microbiome in the progression of multiple diseases, ranging from gastrointestinal conditions to immune-related and psychiatric disorders.
-
NewsStudy links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China
Researchers have discovered a significant association between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC), a cancer prevalent in southern China, where it is 20 times more common than in non-endemic regions of the world.
-
NewsScientists reveal significant burden of liver cancer attributable to hepatitis B and alcohol globally
A new study analyzes and compares the epidemiological trends of liver cancer attributed to hepatitis B (LCHB) and alcohol use (LCAL) over the past 32 years.
-
NewsGut dysbiosis and fecal microbiota transplantation in pancreatic cancer: Current status and perspectives
Emerging studies suggest that manipulating the microbiome, including fecal microbiota transplantation, could present novel approaches to screening, diagnosing, and even treating pancreatic ductal adenocarcinoma.
-
NewsCaterpillar fungus that inspired ‘The Last of Us’ can slow down growth of cancer cells
New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has revealed how it interacts with genes to interrupt cell growth signals.
-
NewsScientists discover how specific E. coli bacteria drive colon cancer
Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin.
-
NewsStudy reveals insights into oral HPV incidence and risks in men across 3 countries
A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil - the virus is linked to up to 90% of all oropharyngeal cancer cases in men in the U.S.
-
NewsPlant fungus provides colorectal cancer drug with a new cellular target
A compound derived from a plant fungus effectively kills colorectal cancer cells by attacking the enzyme DCTPP1, which thus may serve as a potential biomarker for colorectal cancer and a therapeutic target.
-
NewsBacterial vaccine shows promise as cancer immunotherapy
Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
-
NewsNew bacteria-based therapy shows promise for fighting cancer
Researchers have developed a novel method to enhance the cancer-killing properties of bacteria residing in tumors.
-
NewsIn beer yeast, scientists find potential path to starving cancer
The discovery of a surprising way yeast used to brew beer can survive starvation could open the door to new treatments for cancer. The never-before-seen adaptation helps yeast cells go dormant when nutrients are scarce.
-
NewsFermented black garlic extract shows promise against prostate cancer
Researchers test the protective effect of a fermented black garlic extract against inflammation and the progression of prostate cancer in a study conducted on human prostate cancer cell models in the laboratory.
-
NewsChronic stress accelerates colorectal cancer progression by disrupting balance of gut microbiota
Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the progression of colorectal cancer (CRC), opening new avenues for CRC prevention and treatment.
-
NewsZika virus offeres potential as treatment for brain cancer: review
Fourteen studies showed that Zika virus reduced cell viability, inhibited the growth and proliferation of glioma stem cells (GSCs), and decreased Bcl2 expression in central nervous system tumors, potentially enhancing chemotherapy and radiotherapy effects.
-
NewsHibernating ribosomes flip upside down in starving yeast cells
Scientists have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications.
-
NewsScientists engineer new enzyme to produce synthetic genetic material
Researchers have engineered an efficient new enzyme that can produce a synthetic genetic material called threose nucleic acid. The ability to synthesize artificial chains of TNA advances the discovery of therapeutic options to treat cancer and other diseases.
-
NewsMouse model clarifies link between prostate cancer and gut bacteria
Researchers have investigated whether a mouse model of the disease can be used to explore the underlying mechanisms behind the relationship of changes in the composition of gut bacteria and the risk and progression of prostate cancer.
-
NewsGut bacteria engineered to act as tumor GPS for immunotherapies
Cancer researchers have engineered gut derived E. coli bacteria to express immune-activating cytokines on their surfaces, with the idea that the bacteria would move into tumors and induce potent immune responses.
-
NewsFerring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ferring Pharmaceuticals launches state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nadofaragene firadenovec-vncg), an adenovirus vector-based gene therapy.
